glp-1 reactive hypoglycemia after gastric bypass: An emerging complication Hypoglycemia - EMCrit Project

Competing interests The authors declare no competing interests

GLP-1 receptor agonist dosing for weight loss ranges widely across individuals, typically starting at 0.25mg weekly and titrating upward based on tolerability and response

[7] Liraglutide (Saxenda) has similar indications, with NICE Technology Appraisal 664 recommending its use under specific circumstances

The concurrent engagement of all three receptors is hypothesised to produce complementary metabolic effects in pre-clinical models: GLP-1R activation is associated with glucose regulation and appetite modulation, GIPR activation with potentiation of GLP-1mediated responses, and GcgR activation with energy expenditure and hepatic lipid metabolism in laboratory settings

Some insurance companies cover these medications for weight loss, while others only cover them for diabetes management

No, they are very different